Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy - Test2 - elhamkhani - TriplyDB

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy

http://www.wikidata.org/entity/Q30596300

about

Autoimmune Myopathies: Where Do We Stand?Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study Immune-mediated necrotizing myopathy.Skeletal Muscle Involvement in Antisynthetase Syndrome.Integrated classification of inflammatory myopathies.RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis 213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015 Idiopathic inflammatory myopathies overlapping with systemic diseases.A 62-Year-Old Woman with A History of Muscle Pain and Skin Rash for 1 Month.Reply: Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1.Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.Bench to bedside review of myositis autoantibodies.

P2860

Q26744554-DADA5247-E6C1-41EF-812E-231B577523B3 Q37604939-CDBC285C-C927-4B5A-8EBA-4E46321EEF03 Q38702361-D20ED855-D5ED-4768-A848-649EFAB36D9A Q38740583-0C5A2AF1-65B5-4E6D-B23F-6458998802F1 Q39027323-35E74ABC-49B3-471E-9262-B3B7BE9E76A9 Q41111946-FF1D186B-3804-44E5-A411-B1BFDD078C90 Q42365042-527693F9-66EA-43FE-9116-0DF43C72CBC3 Q47401892-1E2CE78A-812E-4136-8DB1-D02F2145A618 Q47902972-62CBD0C1-415B-4B24-902F-0D2EB5614348 Q48692827-C70B7963-68CB-45D1-9446-C1996C9B4814 Q52864090-006DCF2B-4971-4CF4-83A7-BD78A77DA9CF Q55425108-62D4CF76-CDE8-4686-A0FF-9B0EB8784F7F

P2860

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy

http://www.wikidata.org/entity/Q30596300

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@ast

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@en

type

label

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@ast

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@en

prefLabel

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@ast

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@en

P1433

Q30596300-82FCA09A-5203-4097-AB17-E8B7904D99B6

P1476

Q30596300-21251246-5B69-4892-AAFA-5F31086B5E57

P2093

Q30596300-1A06BE96-A3A3-42D6-8FD7-C6E5A413238F

Q30596300-1C06A7DB-B55B-4FCE-8AED-3FF394F098C5

Q30596300-3797FC68-8C22-44DF-85A5-B7639450205B

Q30596300-49A07B5E-2C6E-4040-9495-8624471FFACA

Q30596300-5991F379-DD28-49BE-8841-99E15BFF8E09

Q30596300-65B37D07-B6E1-434C-9458-D6ECB447D7D1

Q30596300-6FD35D49-89A6-49A6-8539-C8801FD744A6

Q30596300-77767F53-0A05-4515-91E2-FD65C404C870

Q30596300-C6000888-2347-4BA1-8411-09983CFB13C7

Q30596300-E8D4A532-6991-46DA-86EE-32F1F0B1CAB5

P2860

Q30596300-0B08A2F7-CC9B-455C-9D7E-19C09EA2B28E

Q30596300-0B84ADC0-BC13-4222-BE66-963F6CF7004F

Q30596300-30B52C09-ED2D-4E6C-834D-7C6313155D2C

Q30596300-39B3E9B8-1339-4B31-ACDD-2524C9F45D58

Q30596300-3F2FE9FB-1B34-4AA2-B455-26C6AB694AB3

Q30596300-4663D29F-DCC2-4333-8056-64CF25953114

Q30596300-47C2585C-4773-463E-AFB8-CDEB17EAA54F

Q30596300-5089CE52-47AE-463F-AC31-9F3F6A678466

Q30596300-51238745-7BC7-4BE3-A4EF-FD9055428A8E

Q30596300-591FE9C5-6BC5-4822-9F11-6F2CA98E9A54

P2888

Q30596300-A1F5DC0E-A2F2-4F1F-9AF9-7AB2D55BD66B

P304

Q30596300-3FB30308-827C-4498-88BC-AFF3DBDDDBD1

P31

Q30596300-A555BED4-8603-4507-B94F-DDDB7300ECEE

P356

Q30596300-28C41D02-A1A4-464F-B1B7-22BCA7F91DA1

P478

Q30596300-D79DDCE7-1566-4F51-89F9-286EF7974B5D

P50

Q30596300-5500BFCC-2930-4865-9CB6-245DCEC8C915

P577

Q30596300-98AFBAC1-5301-45C2-BB79-8886F418309D

P5875

Q30596300-2247D9B0-1D08-43B1-BB65-B50421CD36C8

P6179

Q30596300-414532B8-F6F9-4819-8AEA-0C3BD2E09BE9

P698

Q30596300-B72CF4C8-50D6-478D-8765-ECA1D1B47FBB

P921

Q30596300-F7185DBC-EB4F-40AF-89DE-11A825810653

P932

Q30596300-CD895A66-C3B1-4223-AB37-68C07BB49E04

P356

S40478-014-0154-2

P1433

Acta neuropathologica communications

P1476

Myofiber HLA-DR expression is ...... synthetase-associated myopathy

@en

P2093

Alice Berezne

http://www.w3.org/2001/XMLSchema#string

Anne Cosnes

http://www.w3.org/2001/XMLSchema#string

Dominique Valeyre

http://www.w3.org/2001/XMLSchema#string

Francis Berenbaum

http://www.w3.org/2001/XMLSchema#string

Guillaume Bassez

http://www.w3.org/2001/XMLSchema#string

Jessie Aouizerate

http://www.w3.org/2001/XMLSchema#string

Loïc Guillevin

http://www.w3.org/2001/XMLSchema#string

Marie De Antonio

http://www.w3.org/2001/XMLSchema#string

Odile Dubourg

http://www.w3.org/2001/XMLSchema#string

Olivier Benveniste

http://www.w3.org/2001/XMLSchema#string

P2860

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

Regulation of interferon-gamma during innate and adaptive immune responses

Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease

Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.

Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.

Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.

Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

Idiopathic inflammatory myopathy: autoantibody update.

P2888

s40478-014-0154-2

P304

154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40478-014-0154-2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Francois Jerome Authier

P577

2014-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267731765

http://www.w3.org/2001/XMLSchema#string

P6179

1004822744

http://www.w3.org/2001/XMLSchema#string

P698

25339355

http://www.w3.org/2001/XMLSchema#string

P921

P932

4210467

http://www.w3.org/2001/XMLSchema#string